Skip to content

Amino Acid Composition Reduces Frequency of Common Cold. Results of a Controlled Completely Masked Trial

Amino Acid Composition Reduces Frequency of Common Cold. Results of a Controlled Randomized Completely Masked Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01414335
Enrollment
145
Registered
2011-08-11
Start date
2009-10-31
Completion date
2010-09-30
Last updated
2011-08-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

to Improve the Effectiveness of a Amino Acid Dietary Supplement in Chronic Pharyngeal Infections vs Placebo

Keywords

amino acids, immune system, vitamins, chronic infection, common cold, ear, nose, throat

Brief summary

The purpose of this study is to investigate the effectiveness of a dietary supplement with high dosage of amino acids and vitamins in the treatment of acute and chronic infection of pharyngeal area known as common cold. T

Interventions

DIETARY_SUPPLEMENTamino acid composition

one single pouch (13g) of amino acid mixture and vitamins diluted into 200 ml of still water. This solution was daily oral taken after a meal.

OTHERPlacebo

placebo contained no amino acids and vitamins and was identical in appearance and solution properties.

Sponsors

Kyberg Vital GmbH
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

men and women with at least two episodes of common cold and infection of ear, nose and pharyngeal area.

Exclusion criteria

* people with severe infection like pneumonia, patients expecting an in-patient treatment during the trial, pregnant or breast feeding and people not able to understand the procedure of the treatment

Design outcomes

Primary

MeasureTime frameDescription
outcome of efficacy3 month treatmentFor each study day,participants recorded in a diary rectal temperature, symptoms of sneezing, blocked nose or streaming eyes, whether they had problems to swollow and whether they had headache or pain in arms or legs.

Secondary

MeasureTime frameDescription
outcome of efficacy3 month treatmentSecondary outcome variables: feel the patient fit and able-bodied.

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026